维普中文期刊产品整合服务
38篇 您的检索式:作者名="Barbachano"
    题名 作者 年代 出处 被引量
1Preoperative computed to-mography staging of nonmetastatic colon cancer predicts outcome:lmplications for clinical trials显示文摘Smith NJ Bees N Barbachano Y 2007Br J Cancer2007,96,7:1
2Analysis of the efficacy and toxicity of sorafenib in thyroid cancer:a phase Ⅱ study in a UK based population显示文摘Ahmed M Barbachano Y Riddell A 0,,:1
3Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial显示文摘Chua YJ Barbachano Y Cunnungham D 2010Lancet Oncol2010,11,3:1
4Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials 显示文摘Smith NJ Bees N Barbachano Y 2007Br J Cancer2007,96,7:1
5BOXER : A muhicentre phase Ⅱ trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with liver-only metastases from colorectal canc- er unsuitable for upfront resection 显示文摘Wong R Saffery C Barbachano Y 2011Ann Oncol2011,22,9:1
6Analysis of the effi- cacy and toxicity of sorafenib in thyroid cancer: a phase Ⅱ study in a UK based population 显示文摘Ahmed M Barbachano Y Riddell A 2011Eur J Endocrinol2011,165,2:1
7Preoperative Computed Tomography Staging of Nonmetastatic Colon Cancer Predicts Outcome:Implications for Clinical Trials显示文摘Smith NJ Bees N Barbachano Y 2007Br J Cancer2007,96,7:1
8Detection of occult spinal cord compression with magnetic resonance imaging of the spine显示文摘Venkitaraman R Sohaib SA Barbachano Y 2007Clin Oncol (R Coll Radiol)2007,19,7:1
9A muhicentre study of capecitabine, oxaliplatin plus bevacizumab as perioper- ative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection 显示文摘Wong R Cunningham D Barbachano Y 2011Ann Oncol2011,22,9:1
10Preoperative eompu ted tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials显示文摘Smith N J Bees N Barbachano Y 2007British Journal of Cancer2007,96,7:1
11A randomized multicenter trial of epirubicin,oxaliplatin,and capecitabine (EOC)plus panitumumab in advanced esophagogastric cancer (REAL3)显示文摘Waddell TS Chau I Barbachano Y 0,,:1
12Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials显示文摘A.F.C. Okines D. Gonzalez de Castro D. Cunningham I. Chau R.E. Langley L.C. Thompson S.P. Stenning C. Saffery Y. Barbachano F. Coxon G. Middleton D. Ferry T. Crosby S. Madhusudan J. Wadsley J. Waters M. Hall D. Swinson A. Robinson D. Smith J.S. Reis-Filho 2013European Journal of Cancer2013,,9:1
13Neoadjuvant capecit- abine and oxaliplatin before chemoradiotherapy and total mesorectalexcision in MRIdefined poor-risk rectal cancer:A phase 2 trial 显示文摘Chua YJ Barbachano Y Cunningham D 2010Lancet Onco12010,11,:1
14Prognostic signifi- cance of magnetic resonance imaging - detected extramural vascu- lar invasion in rectal cancer显示文摘Smith NJ Barbachano Y Norman AR 2008Br J Surg2008,95,2:1
15A multicentre study ofcapecitabine, oxaliplatin plus bevacizumab as perioperative treatmentof patients with poor-risk colorectal liver-only metastases not selectedfor upfront resection显示文摘Wong R Cunningham D Barbachano Y 2011Ann Oncol2011,22,9:1
16Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials 显示文摘Smith N J Bees N Barbachano Y 2007Br J Cancer2007,96,7:1
17Neoadjuvant capecitabine and lobaplatin before chemoradiotherapy and total mesorectal excision in M RI-defined poor-risk rectal cancer:a phase 2 trial显示文摘Chua YJ Barbachano Y Cunningham D 2010Lancet Oncol2010,11,3:1
18Detection of oc- cult spinal cord compression with magnetic resonance imaging of the spine 显示文摘Venkitaraman R Sohaib SA Barbachano Y 2007Clin Oncol (R Coil Radiol)2007,19,7:1
19Outcome of early detection and radiotherapy for occult spinal cord compression 显示文摘Venkitaraman R Barbachano Y Dearnaley DP 2007Radiother Oncol2007,85,3:1
20Neoadjuvant capeeitabine and oxali- platin before chemoradiotherapy and total mesorectal excision in MRI-defined poor- risk rectal cancer : a phase 2 trial显示文摘Chua YJ Barbachano Y Cunningham D 2010Lan- cet Oncol2010,11,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费